Adept Biopharma

company

About

Adept Biopharma develops innovative immuno-therapeutics to help cancer patients.

  • 1 - 10

Details

Last Funding Type
Angel
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

Adept Biopharma develops innovative immuno-therapeutics to help cancer patients. Adept Biopharma has mastered the world's leading antibody discovery technology, has a unique NKCE bispecific antibody platform and an ABCC antibody/chemo/cytokine (receptor) trispecific antibody platform, and can also obtain fully human antibodies through external cooperation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Adept Biopharma has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2021 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2021 Angel 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Adept Biopharma is funded by 1 investors. BIOCHING CAPITAL are the most recent investors.
Investor Name Lead Investor Funding Round
BIOCHING CAPITAL Angel